<scp>GLP</scp>‐1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation
Among older adults with T2D, GLP-1RA use was associated with reduced SUD-related hospitalization versus DPP4i use, suggesting potential repurposing for SUD management.
Authors
- Rotana M. Radwan (ORCID: https://orcid.org/0000-0003-0061-0637)
- Amy Sheer (ORCID: https://orcid.org/0000-0001-9589-7727)
- Jiang Bian (ORCID: https://orcid.org/0000-0002-2238-5429)
- Jingchuan Guo (ORCID: https://orcid.org/0000-0001-9799-2592)
- Huilin Tang (ORCID: https://orcid.org/0000-0002-5814-6657)
- Pengyue Zhang (ORCID: https://orcid.org/0000-0002-7381-9303)
- Hao Dai (ORCID: https://orcid.org/0000-0001-7950-3759)
- Darlene Adirika
- Hai Lin (ORCID: https://orcid.org/0000-0002-0358-8714)
- Grant D. Scheiffele
- K Luong
Institutions
- Indiana University Health (US)
- Regenstrief Institute (US)
- University of Florida (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- University of Pennsylvania (US)
- Florida College (US)
Publication Details
- Journal
- Obesity
- Published
- 2025-09-15
- DOI
- https://doi.org/10.1002/oby.70024
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59